dacarbazine has been researched along with Cyst in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, Y; Enatsu, R; Kimura, Y; Mikami, T; Mikuni, N; Wanibuchi, M | 1 |
Avila Medrano, L; Cruz Ortiz, H; Rojo Herrera, G; Torres Lobatón, A | 1 |
1 review(s) available for dacarbazine and Cyst
Article | Year |
---|---|
[Sarcomas of the vulva. Report of 2 cases].
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bartholin's Glands; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Cystectomy; Cysts; Dacarbazine; Diagnosis, Differential; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Leiomyosarcoma; Neoplasm Recurrence, Local; Neurilemmoma; Pelvic Neoplasms; Radioisotope Teletherapy; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Vulvar Neoplasms | 2000 |
1 other study(ies) available for dacarbazine and Cyst
Article | Year |
---|---|
Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carmustine; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cysts; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Drug Evaluation; Drug Implants; Drug Synergism; Female; Follow-Up Studies; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neurosurgical Procedures; Postoperative Hemorrhage; Proportional Hazards Models; Retrospective Studies; Temozolomide; Treatment Outcome; Tumor Microenvironment | 2018 |